Advertisement
Advertisement

ICUI

ICUI logo

ICU Medical Inc

129.14
USD
Sponsored
-0.17
-0.13%
May 21, 14:01 UTC -4
Open

ICU Medical Inc Profile

About

ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.

Info & Links

CEO

Vivek Jain

Headquarters

951 CALLE AMANECER
SAN CLEMENTE, CA 92763, UNITED STATES

Industry

Medical Products

Sector

Medical

Website

www.icumed.com

Auditor

DELOITTE & TOUCHE LLP

Share holders

31

Employees

13,000

ICU Medical Inc Statistics

Valuation Measures

Market Capitalization2

3.23B

Enterprise Value

4.22B

Enterprise Value/EBITDA(ttm)

16.87

Price to Earnings Ratio(ttm)

20.49

Price to Sales(ttm)

1.41

Price to Book(mrq)

1.46

Price to Cash(ytd)

8.63

Profitability

Gross Margin(ttm)

36.90%

Operating Margin(ttm)

6.86%

Profit Margin(ttm)

0.08%

Return on Equity(ttm)

7.33%

Return on Invested Capital(ttm)

0.02%

Return on Assets(ttm)

3.72%

Income Statement

Revenue(ttm)

2.16B

Revenue Per Share(ttm)

86.29

Gross Profit(ttm)

818.16M

EBITDA(ttm)3

250.10M

Net Income Available to Common(ttm)

46.34M

Diluted EPS(ttm)

0.02

Share Statistics

Beta (5Y Monthly)

0.85

52-Week Change

-4.29%

S&P 500 52-Week Change

27.48%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

24.99M

Dividend Yield

0.00%

Float4

24.62M

% Held by Insiders

1.50%

% Held by Institutions

96.10%

Balance Sheet

Total Cash(mrq)

288.33M

Total Cash Per Share(mrq)

11.54

Total Debt(mrq)

1.28B

Total Debt/Equity(mrq)

60.49%

Current Ratio(mrq)

2.39%

Quick Ratio(mrq)

1.15%

Book Value Per Share(mrq)

86.03

Cash Flow

Operating Cash Flow Per Share(ytd)

7.22

Free Cash Flow(ytd)

99.86M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement